TransMedics Is Betting on Kidney Transplants and European Expansion Despite a 40% Stock Drop in Six Months, Yet Long-Term Prospects Remain Strong Jul 4, 2026 Life Science
Significant Improvement in AI Investment Returns Enhances Earnings Prospects, Bullish Logic for Blue-Chip UnitedHealth Is Reshaping Jul 3, 2026 Life Science
Pharmaceutical Giant AbbVie Makes a Major Bet on a New Immunotherapy, and Its Dividend Growth Record Attracts Income-Focused Investors Jul 1, 2026 Life Science
Anthropic Launches Claude Science to Enter Life Sciences, AI Drug Discovery Stocks Tumble in Response Jun 30, 2026 Life Science
Insiders Sell Nearly $900,000 in Stock as Monterosa Medical Faces Key Clinical Data Test Jun 29, 2026 Life Science
Innovative Pipeline Supports Long-Term Value, Moderna Still Has Upside After Doubling in Price Jun 26, 2026 Life Science
Merck KGaA’s $11.3 Billion Bio-Techne Buy Bolsters CGT Ambitions in Biggest Deal Since 2014 Jun 25, 2026 Life Science
Impressive Clinical Trial Data Drives Intellia Therapeutics Up 70% This Year Jun 25, 2026 Life Science
Mid-Cap Biotech Viking Therapeutics Could Emerge as a Potential Challenger to Eli Lilly and Novo Nordisk Jun 23, 2026 Life Science
Can Zumilokibart Become the Next Megablockbuster? Inside AbbVie’s $10.9 Billion Bet on Apogee Jun 22, 2026 Life Science
Why CRISPR Therapeutics Stock Is Stuck Despite Boasting the World’s First Approved CRISPR Therapy Jun 18, 2026 Life Science
